Deutsche Bank
OBIO icon

Deutsche Bank’s Orchestra BioMed OBIO Stock Holding History

Deutsche Bank’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$171K Buy
+39,672
New +$162K ﹤0.01% 3327
2025
Q2 		– Sell
-20,219
Closed -$86.5K – 3693
2025
Q1 		$86.5K Buy
20,219
+8,134
+67% +$40.4K ﹤0.01% 3241
2024
Q4 		$48.3K Hold
12,085
– – ﹤0.01% 3416
2024
Q3 		$62.1K Buy
12,085
+6,002
+99% +$39.2K ﹤0.01% 3318
2024
Q2 		$49.6K Sell
6,083
-1,386
-19% -$8.03K ﹤0.01% 3328
2024
Q1 		$39.4K Sell
7,469
-315
-4% -$2.13K ﹤0.01% 3443
2023
Q4 		$71.1K Buy
+7,784
New +$53.1K ﹤0.01% 3355
2023
Q1 		– Sell
-15,041
Closed -$150K – 3957
2022
Q4 		$150K Hold
15,041
– – ﹤0.01% 3112
2022
Q3 		$149K Buy
+15,041
New +$149K ﹤0.01% 3121

Other funds holding OBIO

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Deutsche Bank's OBIO Position: Q2 2026 in Review

Deutsche Bank opened a new position in Orchestra BioMed (OBIO) in Q2 2026: 39,672 shares worth $171K. The stake represents ﹤0.01% of the portfolio and ranks #3327 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in OBIO as recently as Q1 2025.

Deutsche Bank first reported a position in OBIO in Q3 2022 and has held it in 9 quarters since. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • Deutsche Bank held 39,672 shares of Orchestra BioMed worth $171K as of Q2 2026.
  • Orchestra BioMed was a new Deutsche Bank position in Q2 2026.
  • Orchestra BioMed made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3327 holding.
  • Deutsche Bank first reported a position in Orchestra BioMed in Q3 2022 and has held it in 9 quarters since.
  • 77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.